A new drug-eluting spacer infused with steroids may be the answer to an unmet medical need for patients with chronic rhinosinusitis. The device, from SinuSys (Palo Alto, California), is being studied in a clinical trial for use after functional endoscopic sinus surgery (FESS).
Read More
